Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as hopeful https://hamzahgwtr236830.activosblog.com/37648386/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements